Physician profile
Ryan Didde
NPI 1639733470
$2,898.11
in general payments reported to CMS, 2019-2025
18 companies · $1,008 in 2025
The $1,008 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.37 · 2021: $285 · 2022: $755 · 2023: $239 · 2024: $591 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,445 · Travel and Lodging: $385 · Education: $8.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.81 |
| Travel and Lodging | $384.79 |
| Education | $8.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,308.12 | 2020-2025 | Lumenis Pulse 120h, Moses, General - Kidney Stone Disease |
| Karl Storz Endoscopy-America | $328.44 | 2021-2024 | N.A. |
| Janssen Scientific Affairs, LLC | $216.49 | 2023-2024 | Balversa, Erleada, Pipeline |
| Coloplast Corp | $200.02 | 2021-2025 | |
| Urogen Pharma, INC. | $151.02 | 2025 | |
| Procept Biorobotics Corporation | $148.30 | 2024 | Aquabeam System |
| Cook Medical LLC | $142.55 | 2021-2025 | Resonance |
| Astellas Pharma US INC | $85.05 | 2022 | |
| Innovation Technologies INC | $84.20 | 2022 | |
| Abbvie INC. | $71.85 | 2022-2024 | |
| Olympus America INC. | $32.84 | 2025 | Itind System |
| Photocure INC | $32.77 | 2022 | |
| Urovant Sciences INC | $19.60 | 2022 | |
| Axonics, INC. | $18.20 | 2023 | Axonics |
| Laborie Medical Technologies Corp. | $17.32 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $15.03 | 2023 | Gemtesa |
| Myovant Sciences INC. | $13.29 | 2021 | |
| Ambu INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Didde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.